NMRA Annual Retained Earnings
-$703.43 M
-$235.93 M-50.46%
31 December 2023
Summary:
As of January 23, 2025, NMRA annual retained earnings is -$703.43 million, with the most recent change of -$235.93 million (-50.46%) on December 31, 2023. During the last 3 years, it has fallen by -$604.14 million (-608.44%). NMRA annual retained earnings is now -3349585.71% below its all-time high of -$21.00 thousand, reached on December 1, 2019.NMRA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMRA Quarterly Retained Earnings
-$888.40 M
-$72.55 M-8.89%
30 September 2024
Summary:
As of January 23, 2025, NMRA quarterly retained earnings is -$888.40 million, with the most recent change of -$72.55 million (-8.89%) on September 30, 2024. Over the past year, it has dropped by -$131.25 million (-17.33%). NMRA quarterly retained earnings is now -794.73% below its all-time high of -$99.29 million, reached on December 1, 2020.NMRA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMRA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.5% | -17.3% |
| 3 y3 years | -608.4% | -116.7% |
| 5 y5 years | -10000.0% | -116.7% |
NMRA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -109.0% | at low | -163.9% | at low |
| 5 y | 5-year | <-9999.0% | at low | -794.7% | at low |
| alltime | all time | <-9999.0% | at low | -794.7% | at low |
Neumora Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$888.40 M(+8.9%) |
| June 2024 | - | -$815.86 M(+7.8%) |
| Mar 2024 | - | -$757.15 M(+7.6%) |
| Dec 2023 | -$703.43 M(+50.5%) | -$703.43 M(+18.3%) |
| Sept 2023 | - | -$594.70 M(+9.8%) |
| June 2023 | - | -$541.68 M(+15.9%) |
| Dec 2022 | -$467.51 M | -$467.51 M(+14.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -$410.02 M(+8.0%) |
| Mar 2022 | - | -$379.65 M(+12.8%) |
| Dec 2021 | -$336.61 M(+239.0%) | - |
| Dec 2021 | - | -$336.61 M(+8.7%) |
| Sept 2021 | - | -$309.64 M(+211.8%) |
| Dec 2020 | -$99.29 M(>+9900.0%) | -$99.29 M |
| Dec 2019 | -$21.00 K | - |
FAQ
- What is Neumora Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Neumora Therapeutics?
- What is Neumora Therapeutics annual retained earnings year-on-year change?
- What is Neumora Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly retained earnings year-on-year change?
What is Neumora Therapeutics annual retained earnings?
The current annual retained earnings of NMRA is -$703.43 M
What is the all time high annual retained earnings for Neumora Therapeutics?
Neumora Therapeutics all-time high annual retained earnings is -$21.00 K
What is Neumora Therapeutics annual retained earnings year-on-year change?
Over the past year, NMRA annual retained earnings has changed by -$235.93 M (-50.46%)
What is Neumora Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NMRA is -$888.40 M
What is the all time high quarterly retained earnings for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly retained earnings is -$99.29 M
What is Neumora Therapeutics quarterly retained earnings year-on-year change?
Over the past year, NMRA quarterly retained earnings has changed by -$131.25 M (-17.33%)